239 risk; while, crotonase (K01715) and β-hydroxybutyryl-CoA dehydrogenase (K00074) in the acetyl-CoA 240 pathway were enriched in participants with elevated CM risk. Notably, the abundance of predictive genes 241 that encode for glutaconyl-CoA decarboxylase (α, β subunits) (K01615) in the glutarate pathway and the 242 4-hydroxybutyryl-CoA dehydratase (K14534) in the 4-aminobytyrate/succinate pathway were enriched in 243 participants with elevated CM risk (adjusted for country, sex, age and BMI, fdr-corrected p < 0.05; Figure   244 2d).
246
We also explored whether gut bacterial functions were associated with each of the 5 individual CM risk 247 factor within each of the countries. Gut microbial predicted genes involved in LPS and SCFA biosynthesis 248 pathways showed that genes involved in the butyrate synthesis via lysine, glutarate and 4-249 aminobutyrate/succinate pathways and LPS synthesis pathway were differentially enriched among the 250 cohort with an elevated individual CM risk factor (supplementary Figure 8-11 ). Specifically, predicted 251 genes involved in LPS biosynthesis pathways were enriched among participants with an elevated waist 252 circumference in Ghana and US; participants with an elevated blood pressure in Ghana and Jamaica;
253 participants with an elevated fasted blood glucose in Jamaica and the US, and those with low HDL in 254 South Africa and the US. As the butyrate synthesis via lysine, glutarate and 4-aminobutyrate/succinate 255 pathways, predicted genes involved in the glutarate pathway were significantly enriched in participants 256 with a high waist circumference in South Africa and Ghana, and also participants with low HDL 257 concentrations in the US and South Africa; predicted genes involved in the lysine pathway were enriched 258 in participants with elevated blood pressure in Ghana; and predicted genes involved in the 4- 
261
262 Generalized linear models (GLM) were applied to explore the associations between alpha diversity, 263 bacterial taxa and predicted functional genes and total CM risk (captured as the sum of CM risk factors 264 in each participant). For instance, there was a significant positive correlation between the proportion of 265 KEGG ID K01615 in the glutarate pathway and K14534 in the 4-aminobytyrate/succinate pathway and 266 total CM risk score (i.e. a z-score transformation to generate continuous discrete measurements, 267 controlling for country, age, sex, and BMI, p <0.05, see methods for more details). However, there were 268 no significant associations between diversity or differential bacterial taxa and total CM risk (p >0.05). To 269 explore whether the gut microbiota predicted elevated CM risk (three out of the five risk factors), random 270 forest regression was used to determine the gut bacterial ESVs against the total CM risk (z-score 271 transformed) pooling the 3 sites with CM risk data. Elevated CM risk could be predicted by gut-associated 272 ESVs and explained almost 15% of the elevated CM risk variance among those with CM risk data.
273
274 Oral-associated bacterial diversity associates with country of origin and CM risk factors 275 On the other hand, oral microbiota diversity was associated with the country of origin, but not with the 276 individual CM risk factors. Shannon diversity was significantly greater among the Ghanaians compared 277 to the US participants (adjusted for age, sex and BMI, p <0.05; Supplementary Figure 12) . As oral 278 microbial alpha diversity was significantly different between countries, we correlated CM risk against 279 alpha diversity for each country independently, and found that none of the CM risk factors were 280 significantly associated with oral microbial alpha diversity (p >0.05, Supplementary Figure 13 ).
281 However, oral microbial beta diversity was significantly different between participants from different 282 countries (fdr-corrected p <0.01, Supplementary Figure 14) , and therefore, tests of association were 283 performed separately for each country. In the US sample, weighted UniFrac distance was significantly 284 different between individuals with either high and normal waist circumference (fdr-corrected p <0.01) and 285 similarly, between participants with either elevated and normal glucose concentrations (fdr-corrected p 286 <0.05, Supplementary Figure 15 ). Unweighted UniFrac distances were significantly different between 287 individuals with either elevated and normal waist circumference in the US (fdr-corrected p ≤ 0.01), Ghana 288 (fdr-corrected p <0.05), and South Africa (fdr-corrected p <0.05) (Supplementary Figure 16) . In the US 289 alone, unweighted UniFrac was significantly different by HDL risk (fdr-corrected p <0.05) Figure 16) . Therefore, oral beta diversity, and hence microbial structure, was 291 significantly associated with several CM risk factors, but similarly differed by country, suggesting that 292 environmental factors are critical for inter-individual dissimilarities in oral microbial composition Figure 17) . However, both weighted and unweighted UniFrac distance 300 were significantly differentiated by CM risk (fdr-corrected p <0.01, Figure 3a, 3b) 
(Supplementary
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To determine whether the taxa could identify participants with elevated CM risk, we once again used 320 GLM to determine the association between the differential proportional oral bacterial taxa and total CM 321 risk (sum of the number of CM risk factors for each participant). There was a significantly positive 322 association between the proportion of a Streptococcus ESV and total CM risk (z-score transformation), 323 controlling for country, age, and sex p <0.05). To test whether the oral microbiota can identify participants 324 with the elevated CM risk phenotype, random forest regression was used to examine the association of 325 oral bacterial ESVs against CM risk (z-score transformed). Among participants with elevated CM risk, 326 oral bacterial ESVs, accounted for almost 8% of the variance.
327
328 Correlation of beta diversity between gut and oral microbiota 329 Finally, to explore whether the beta diversity trends seen in the oral microbiota correlated with those in 330 the gut microbiota, we applied a Mantel test using both unweighted and weighted UniFrac distance 
337
338 Discussion 339 In our study of African-origin adults from Ghana, South Africa, Jamaica and the US, we performed a 340 comprehensive analysis exploring the relationship between the gut and oral microbiota and elevated CM 341 risk, representing 4 geographically diverse countries spanning an epidemiologic transition. Overall, our 342 results provide evidence that the gut and oral microbiota may potentially be both predictive as well as a 343 therapeutic target for elevated CM risk, and is in line with previous evidence that the human microbiota 344 are associated with CM risk (40) .
345
346 Consistent with previous studies(9, 41), we found that the gut microbial alpha diversity was significantly 347 lower in participants with elevated CM risk. However, these associations are mostly geographical and 348 dependent on the type of CM risk factor, e.g. for elevated blood pressure, the association was only found 349 among South Africans and Ghanaians, while only Jamaicans had differences for elevated fasted blood 350 glucose. Similarly, gut bacterial beta diversity was also significantly different between participants with 351 an elevated waist circumference, elevated blood pressure, hypertriglyceridemia or low HDL concentration, 352 compared with their healthy counterparts. Although again, the associations differed by country, e.g. for 353 an elevated waist circumference, the associations were only found among the South African and 354 Ghanaian participants, and for low HDL concentration, only among the US participants.
355
356 Previous studies have reported conflicting results as to which specific bacterial taxa associate with CM 357 risk factors (11-13, 17, 18) . In our study, gut bacterial ESVs annotated to family Lachnospiraceae were 358 significantly enriched in participants with the elevated CM risk phenotype, along with individual risk factors, 359 including elevated waist circumference and hypertriglyceridemia. Previously, a number of studies have 360 found that an enrichment of Lachnospiraceae was associated with the development of obesity, insulin 361 resistance and other metabolic disorders (42) (43) (44) (45) (46) . Notably, participants with an elevated waist 362 circumference also showed an enrichment for the genus Streptococcus, which has previously been found 363 to be enriched in some CM diseases (17) . In our study, participants with healthy waist circumferences, 364 and blood pressure and a normal fasting blood glucose exhibited a significant enrichment of the 365 Ruminococcaceae family (supplementary results), which includes several kinds of beneficial bacteria 366 known to be negatively correlated to metabolic disease and associated with lower CM risk, e.g. genus 367 Faecalibacterium (47, 48) and genus Oscillospira (49) . Similarly, gut bacterial ESVs annotated to the 368 Clostridiaceae and Peptostreptococcaceae families and Prevotella genus were enriched in participants 369 with a lower total CM risk as well as individual CM risk factors, e.g. healthy waist circumferences and 370 normal fasting blood glucose levels, consistent with previous research, reporting a negative association 371 with obesity or other CM risk factors (18, 50, 51 (19, 20) . Of note, the predicted relative proportion of genes that encode for enzymes involved 381 in butyrate synthesis pathway suggested that the lysine pathway, glutarate pathway, and 4-382 aminobytyrate/succinate pathway were significantly enriched in individuals with elevated CM risk and 383 also individual risk factor. Butyrate can be synthesized via different substrates, driven by enzymes that 384 are produced and secreted by different bacteria (54) . While the most common pathway for butyrate 385 synthesis is via pyruvate and acetyl-coenzyme A, other less-dominant pathways include amino-acids 386 (lysine, glutarate and 4-aminobytyrate/succinate) as substrates via the 4-aminobutyrate pathway, which 387 can produce pro-inflammatory byproducts (54) and are related with obesity. Together, these results 388 suggest that the gut microbial metabolic functional potential of participants with elevated CM risk had a 389 marked inflammation-driving capacity, which may influence host systemic inflammatory levels and may 390 ultimately lead to the CM disease consequence.
391
392 While the impact of ethnicity on the core of gut microbiota has been demonstrated by several studies (55, 393 56), exploring the impact of ethnicity and the associations between gut microbiota and CM risk has not 394 been performed to date. Some studies find that there is a decrease in the gut microbial alpha-diversity 395 that is associated with CM risk from different ethnicities, e.g. Danish obese individuals when compared 396 to non-obese individuals9 and obese compared with lean in a mid-western US female adolescent twin 397 cohort study (41) . Similarly, previous studies find that there is a shared alteration in the gut microbial 398 composition of the individuals with elevated CM risk and adiposity derived from different ethnicities. For 399 example there was an adiposity-related enrichment of Lachnospiraceae in the gut microbiota of 400 participants enrolled in the Twins UK cohort study (46) , as well as among British obese individuals(45), 401 and obese, Colombian subjects (57) with increased cardiometabolic risk, and finally among individuals 402 in the midst of Westernization(58) when compared to the lean individuals, respectively. Interestingly, the 403 association between TMAO and cardiovascular disease has been found to be significantly greater in 404 whites compared to blacks (24) . In our study of African-origin adults, there was no significant association 405 between predicted genes involved in TMAO biosynthetic pathway and total CM risk or individual CM risk 
469 Lifestyle and biochemical measurements
470 All measurements were made at research clinics located in the respective communities. Weight and 471 height were measured. Participants were asked to provide an early morning fecal sample, using a 472 standard collection kit (EasySampler stool collection kit, Alpco, NH) at their home. Fecal samples were 507 The contribution of CM risk factors and environmental factors (sex, age, BMI, sleep, smoke and alcohol 508 consumption) to the overall weighted and unweighted UniFrac dissimilarities in gut and oral microbiota 509 composition was also assessed using PERMANOVA (R function adonis (vegan), 999 permutations), 510 which decomposes the dissimilarity matrix into 'variance' explained by each covariate. The obtained R 2 511 gives the proportion of variability observed in the entire dissimilarity matrix that can be independently 512 attributed to the studied variables.
513
514 For taxonomic comparisons, relative abundances based on all obtained reads were used. We used the 515 QIIME2 plugin "q2-feature-classifier" and the Naïve Bayes classifier(75) that was trained on the 516 metagenome annotation package Greengenes13.8(76) 99% operational taxonomic units (OTUs) full-517 length sequences to obtain the taxonomy for each ESV. Significantly differential ESVs were determined 518 using the statistical framework called analysis of composition of microbiomes (ANCOM)(71) for two 519 group comparisons. FDR correction was used to correct for multiple hypothesis testing. Results were 520 adjusted for BMI, age, sex and country. 521 522 A two-side Mantel test using Spearman correlation coefficients (999 permutations) was applied to identify 523 the correlation between the beta diversity of the oral and the gut microbiota, with both unweighted and 524 weighted UniFrac distance matrices in software R with the function "mantel.test" (77) .
526
To test for correlations between oral microbiota and the Shannon index or ESVs, which their relative 527 abundances was greater than 1% and are also significantly correlated with CM risk in gut microbiota, 528 random forest regression and generalized linear models (GLM) were performed. Random forest 529 regression was done with 1,000 regression trees based on 10-fold cross-validation and performed with 530 QIIME2 plugin "qiime sample-classifier regress-samples" and the Random Forest regressor in the R 531 programming environment. A randomly drawn 80% of samples were used for model training and the 532 remaining 20% were used for validation.
533
534 Metagenome functional predictions of the microbial pathways 535 We used Piphillin an algorithm to predict the functional profiles of the microbiome (39 triglyceridemia and low HDL-cholesterolemia in USA, RSA, and Ghana. fdr, false discovery rate.
